 | Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to Hold at Zacks Investment Research
marketbeat.com - February 11 at 12:45 AM |
 | Neurocrine Biosciences Target of Unusually Large Options Trading (NASDAQ:NBIX)
americanbankingnews.com - March 3 at 1:59 PM |
| Neurocrine Biosciences (NASDAQ:NBIX) Shares Down 7.3%
americanbankingnews.com - March 2 at 7:44 PM |
 | Noteworthy Tuesday Option Activity: NBIX, LZB, ABR
nasdaq.com - March 2 at 5:21 PM |
| Neurocrine Biosciences: Luvadaxistat Fails To Meet Primary Endpoint In Phase II INTERACT Study
nasdaq.com - March 2 at 12:20 PM |
 | Neurocrine Biosciences Announces Top-Line Results from Phase II INTERACT Study Evaluating Luvadaxistat (NBI-1065844) for the Treatment of Negative Symptoms and Cognitive Impairment Associated with Schizophrenia (CIAS)
finance.yahoo.com - March 2 at 12:20 PM |
| Neurocrine/Takeda's Luvadaxistat Fails To Improve Schizophrenia Symptom Severity
finance.yahoo.com - March 2 at 12:20 PM |
| Neurocrine Biosciences to Present at the Cowen 41st Annual Health Care Conference
finance.yahoo.com - February 23 at 8:00 PM |
| Reviewing Neurocrine Biosciences (NASDAQ:NBIX) and Vaxcyte (NASDAQ:PCVX)
americanbankingnews.com - February 18 at 2:20 AM |
| Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells 1,700 Shares of Stock
americanbankingnews.com - February 12 at 9:38 PM |
|
| Noteworthy Friday Option Activity: NBIX, WFC, RNG
nasdaq.com - February 12 at 7:05 PM |
 | Neurocrine Biosciences Upping Marketing Spend To Support Its Platform
seekingalpha.com - February 11 at 12:10 AM |
| Matt Abernethy Sells 2,910 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
americanbankingnews.com - February 10 at 12:50 AM |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells $98,739.75 in Stock
americanbankingnews.com - February 9 at 11:14 PM |
| Eiry Roberts Sells 2,363 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock
americanbankingnews.com - February 9 at 9:56 PM |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells $276,495.52 in Stock
americanbankingnews.com - February 9 at 9:56 PM |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells $1,221,905.50 in Stock
americanbankingnews.com - February 9 at 9:24 PM |
| Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 5 at 11:39 PM |
| NBIX Mar 2021 115.000 call
au.finance.yahoo.com - February 5 at 6:39 PM |
| NBIX Aug 2021 110.000 put
au.finance.yahoo.com - February 5 at 6:39 PM |
| Neurocrine Biosciences Inc (NBIX) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 5 at 1:07 AM |
| Neurocrine Biosciences Inc Q4 adjusted earnings Beat Estimates
nasdaq.com - February 4 at 8:07 PM |
| Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - February 4 at 8:07 PM |
| Recap: Neurocrine Biosciences Q4 Earnings
finance.yahoo.com - February 4 at 8:07 PM |
| Neurocrine Biosciences (NBIX) Q4 Earnings Top Estimates
finance.yahoo.com - February 4 at 8:07 PM |
| NBIX Makes Notable Cross Below Critical Moving Average
nasdaq.com - February 1 at 3:44 PM |
| Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2020 Financial Results
finance.yahoo.com - January 20 at 8:51 PM |
| Neurocrine, Ionis, Vertex: Underperforming Healthcare Stocks Poised To Recover
nasdaq.com - January 20 at 4:58 AM |
| Voyager Therapeutics: Complicated Story In Gene Therapy Development
seekingalpha.com - January 19 at 6:56 PM |
| Neurocrine Biosciences Shares Rise Despite Disappointing Q4 Earnings; Target Price $121
finance.yahoo.com - January 8 at 7:27 PM |
|
| Bullish Two Hundred Day Moving Average Cross - NBIX
nasdaq.com - January 8 at 2:26 PM |
| Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones
finance.yahoo.com - January 8 at 9:25 AM |
| Neurocrine Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 7:56 PM |
| Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
finance.yahoo.com - December 22 at 6:01 PM |
| Should You Be Adding Neurocrine Biosciences (NASDAQ:NBIX) To Your Watchlist Today?
finance.yahoo.com - December 21 at 2:39 PM |
| Is NBIX A Good Stock To Buy Now?
finance.yahoo.com - December 21 at 2:39 PM |
 | 5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential
msn.com - December 21 at 9:39 AM |
| Noteworthy Friday Option Activity: RARE, NBIX, KRA
nasdaq.com - December 18 at 6:41 PM |
 | Neurocrine Stock Looks Attractive In the Wake Of A 30% Correction
forbes.com - December 16 at 1:48 PM |
| Is Neurocrine Biosciences (NBIX) a Smart Long-term Buy?
finance.yahoo.com - December 11 at 9:26 AM |
| First Week of January 2021 Options Trading For Neurocrine Biosciences (NBIX)
nasdaq.com - November 20 at 2:59 PM |
| Neurocrine Biosciences Announces Repurchase of Convertible Notes
finance.yahoo.com - November 19 at 8:28 AM |
| Neurocrine Biosciences Hit By Multiple Setbacks
seekingalpha.com - November 17 at 6:15 AM |
| Results: Neurocrine Biosciences, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
finance.yahoo.com - November 13 at 1:05 PM |
| Neurocrine Biosciences Inc (NBIX) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 10 at 8:42 PM |
| Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 5:38 AM |
 | Recap: Neurocrine Biosciences Q3 Earnings
benzinga.com - November 9 at 6:14 PM |
| Neurocrine Biosciences EPS misses by $0.28, misses on revenue, FY outlook
seekingalpha.com - November 9 at 6:14 PM |
| Neurocrine Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 6:14 PM |
| Neurocrine Biosciences Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 9 at 6:14 PM |
| Neurocrine Biosciences (NBIX) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 9 at 6:14 PM |
